Kidney protection: How to prevent or delay chronic renal failure

Geriatrics

Volumn 51, Issue 8, 1996, Pages 28-35

  Steinman, Theodore I ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; CALORIC INTAKE; CHRONIC KIDNEY FAILURE; DIETARY INTAKE; HEART PROTECTION; HUMAN; HYPERTENSION; PROTEIN INTAKE; REVIEW;

ANEMIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CREATININE; DIETARY PROTEINS; ENERGY INTAKE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC;

EID: 0030320250     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. United States Renal Data System. USRDS 1994 Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MD: 1994.
2. Klahr S, Levey AS, Beck GJ, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 1994; 330:877-84.
3. Modification of Diet in Renal Disease Study Group. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. J Am Soc Nephrol 1995; 5:2037-47.
4. Kopple JD, Houser H, Steinman TI, Teschan P, Berg R. Nutritional status of patients with different level of chronic renal insufficiency: Modification of diet in renal disease (MDRD) study group. Kidney Int 1989; 36(suppl 27):S184-94.
5. Goodship THJ, Mitch WE, Hoerr RA, Wagner DA, Steinman TI, Young VR. Adaptation to low-protein diets in renal failure: Leucine turnover and nitrogen balance. J Am Soc Nephrol 1990; 1:66-75.
6. Praga M, Hernandez E, Montoya C, Andres A, Ruilope LM, Rodicio JL. Long term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria. Am J Kidney Dis 1992; 3:240-8.
7. Cattran D, Greenwood C, Ritchie S. Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: A comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. Am J Kidney Dis 1994; 23:247-54.
8. Slataper R, Vicknair N, Sadler R, Bakris GI. Comparative effects of different antihypertensive treatments on progression of diabetic renal disease. Arch Intern Med 1993; 153:973-80.
9. Maniar S, Laouari D, Dechaux M, et al. In vivo unaltered muscle protein synthesis in experimental chronic metabolic acidosis. Kidney Int. 1994; 46:1705-12.
10. May RC, Kelly RA, Mitch WE. Metabolic acidosis stimulates protein degradation in rat muscle by a glucocorticoid dependent mechanism. J Clin Invest 1986; 77:614-21.
11. Williams B, Walls J. Metabolic acidosis: A significant catabolic factor in chronic renal failure? J Nephrol 1994; 7:73-5.
12. Schrock H, Goldstein I. Inter-organ relationships for glutamine metabolism in normal and acidotic rats. Am J Physiol 1981; 240:E519-25.
13. Papadoyannakis NJ, Stefanides CJ, McGeowan M. The effect of correction of metabolic acidosis on nitrogen and potassium balance of patients with chronic renal failure. Am J Clin Nutr 1984; 40:623-7
14. Reaich D, Channon SM, Schrimgeour CM, Daley SE, Wilkinson R, Goodship THJ. Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation. Am J Physiol 1993; 265:E230-5.
15. Messa P, Vallone C, Mioni G, et al. Direct in vivo assessment of parathyroid hormone-calcium relationship curve in renal patients. Kidney Int 1994; 46:1713-20.
16. 2D receptors are decreased in parathyroid glands from chronically uremic dogs. Kidney Int 1989; 35:19-23.
17. Rodriguez M, Martin-Malo A, Martinez ME, Torres A, Fensefeld AJ, Liach F. Calcemic response to parathyroid hormone in renal failure: Role of phosphorus and its effect on calcitriol. Kidney Int 1991; 40:1055-62.
18. Drueke TB, Kubrusly M. Pathogenesis of secondary hyperparathyroidism of chronic renal failure. J Nephrol 1994; 7:139-47.
19. Eschbach JW, Aquiling T, Haley NR, Fan MH, Blagg CR. The long-term effects of recombinant human erythropoietin on the cardiovascular system. Clin Nephrol 1992; 38:S98-103.
20. Kramer BK, Ritz E. Is inhibition of the angiotensin-converting enzyme the treatment of choice in diabetic nephropathy? J Nephrol 1994; 7:268-70.
21. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329:1456-62.
22. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-86.